Capricor Therapeutics (CAPR) Short Interest Ratio & Short Volume $18.60 -0.86 (-4.42%) (As of 11/4/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Capricor Therapeutics Short Interest DataCapricor Therapeutics (CAPR) has a short interest of 6.18 million shares. This marks a 17.94% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.1, indicating that it would take 2.1 days of the average trading volume of 2.53 million shares to cover all short positions.Current Short Interest6,180,000 sharesPrevious Short Interest5,240,000 sharesChange Vs. Previous Month+17.94%Dollar Volume Sold Short$133.49 millionShort Interest Ratio2.1 Days to CoverLast Record DateOctober 15, 2024Outstanding Shares45,410,000 sharesPercentage of Shares Shorted13.61%Today's Trading Volume1,100,766 sharesAverage Trading Volume2,531,895 sharesToday's Volume Vs. Average43% Short Selling Capricor Therapeutics? Sign up to receive the latest short interest report for Capricor Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCAPR Short Interest Over TimeCAPR Days to Cover Over TimeCAPR Percentage of Float Shorted Over Time Ad Timothy SykesTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…Click here to see a unique election-year trade Capricor Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/20246,180,000 shares $133.49 million +17.9%N/A2.1 $21.60 9/30/20245,240,000 shares $79.70 million -30.4%N/A2.1 $15.21 9/15/20247,530,000 shares $34.56 million +0.8%N/A8.5 $4.59 8/31/20247,470,000 shares $34.14 million +6.7%N/A19.5 $4.57 8/15/20247,000,000 shares $27.30 million +12.7%N/A16.5 $3.90 7/31/20246,210,000 shares $25.21 million +5.8%N/A14.4 $4.06 Get the Latest News and Ratings for CAPR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Capricor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/15/20245,870,000 shares $27.35 million +25.7%N/A13.6 $4.66 6/30/20244,670,000 shares $22.28 million +3.6%N/A10.8 $4.77 6/15/20244,510,000 shares $23.32 million -1.3%N/A12.6 $5.17 5/31/20244,570,000 shares $25.96 million +8.6%N/A12 $5.68 5/15/20244,210,000 shares $22.44 million +1.7%N/A11.6 $5.33 4/30/20244,140,000 shares $21.82 million +15.3%N/A12.8 $5.27 4/15/20243,590,000 shares $21.04 million +2.6%N/A12 $5.86 3/31/20243,500,000 shares $23.77 million +8.4%N/A13 $6.79 3/15/20243,230,000 shares $20.64 million +19.6%N/A11.8 $6.39 2/29/20242,700,000 shares $11.34 million +0.8%N/A10.3 $4.20 2/15/20242,680,000 shares $10.10 million -0.4%N/A11.5 $3.77 1/31/20242,690,000 shares $10.87 million No ChangeN/A11.2 $4.04 1/15/20242,690,000 shares $11.89 million +14.5%N/A11 $4.42 12/31/20232,350,000 shares $11.49 million +10.3%N/A9.6 $4.89 12/15/20232,130,000 shares $9.24 million +45.9%N/A7.2 $4.34 11/30/20231,460,000 shares $4.34 million +7.4%N/A5.8 $2.97 11/15/20231,360,000 shares $4.37 million +10.6%N/A5.4 $3.21 10/31/20231,230,000 shares $3.47 million +1.7%N/A4.7 $2.82 10/15/20231,210,000 shares $3.46 million +80.8%N/A5 $2.86 9/30/2023669,100 shares $2.29 million +22.2%N/A3.2 $3.42 9/15/2023547,600 shares $3.43 million +36.4%N/A4.4 $6.26 8/31/2023401,500 shares $2.60 million +27.3%N/A3.2 $6.48 8/15/2023315,500 shares $2.25 million +14.0%N/A3.1 $7.14 7/31/2023276,700 shares $1.22 million +0.8%N/A3.7 $4.40 7/15/2023274,500 shares $1.23 million -0.3%N/A4 $4.48 6/30/2023275,200 shares $1.32 million +6.5%N/A3.7 $4.78 6/15/2023258,400 shares $1.24 million +0.8%N/A3.5 $4.80 5/31/2023256,300 shares $1.16 million -13.1%N/A3.8 $4.53 5/15/2023294,800 shares $1.24 million +11.0%N/A4.1 $4.19 4/30/2023265,700 shares $1.03 million +0.5%N/A3.5 $3.89 4/15/2023264,500 shares $1.16 million -3.8%N/A2.9 $4.38 3/31/2023274,800 shares $1.16 million -22.3%N/A2.9 $4.22 3/15/2023353,500 shares $1.58 million +4.5%N/A3.5 $4.47 2/28/2023338,200 shares $1.54 million +8.7%N/A3.3 $4.55Market "Famine" Coming (Ad)Market Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicted the 2020 crash a month before it happened...For a limited time, he's revealing his latest forecast here. 2/15/2023311,100 shares $1.25 million -5.2%N/A2.9 $4.03 1/31/2023328,300 shares $1.39 million -4.3%N/A2.8 $4.22 1/15/2023343,100 shares $1.50 million +0.7%N/A2.8 $4.38 12/30/2022340,900 shares $1.32 million +9.4%N/A2.5 $3.86 12/15/2022311,700 shares $1.21 million +30.8%N/A1.9 $3.89 11/30/2022238,400 shares $1.07 million -8.5%N/A1.4 $4.47 11/15/2022260,600 shares $1.06 million +5.3%N/A1.4 $4.09 10/31/2022247,500 shares $1.38 million -16.9%N/A1.2 $5.56 10/15/2022297,800 shares $1.74 million -10.0%N/A1.5 $5.83 9/30/2022330,900 shares $1.99 million +55.3%N/A1.7 $6.00 9/15/2022213,100 shares $1.25 million -25.5%N/A1.2 $5.87 8/31/2022286,100 shares $1.67 million -5.9%N/A1.7 $5.82 8/15/2022304,100 shares $1.49 million -15.2%N/A2.2 $4.89 7/31/2022358,500 shares $1.65 million -9.1%N/A3.2 $4.61 7/15/2022394,500 shares $1.99 million -9.6%N/A3.4 $5.05 6/30/2022436,600 shares $1.52 million -12.5%N/A3.8 $3.49 6/15/2022499,100 shares $2.05 million -2.7%2.5%3.1 $4.11 5/31/2022512,800 shares $1.86 million -8.6%N/A3 $3.63 5/15/2022561,000 shares $1.72 million -4.4%N/A3 $3.06 4/30/2022586,600 shares $1.86 million -9.2%N/A2.9 $3.17 4/15/2022645,800 shares $2.12 million -7.1%N/A1.7 $3.29 3/31/2022695,100 shares $2.38 million -3.2%N/A1.8 $3.43 3/15/2022718,300 shares $2.97 million -20.7%N/A2.1 $4.14 2/28/2022905,200 shares $3.67 million +4.1%N/A2.6 $4.05 2/15/2022869,900 shares $3.76 million -7.0%N/A2.5 $4.32 1/31/2022934,900 shares $3.34 million +69.6%N/A2.6 $3.57 1/15/2022551,200 shares $1.70 million -18.3%N/A1.9 $3.09 12/31/2021675,000 shares $1.98 million -13.7%N/A3.5 $2.93 12/15/2021781,900 shares $2.47 million -12.1%N/A1.2 $3.16 11/30/2021889,000 shares $3.00 million -2.5%N/A1.3 $3.37 11/15/2021912,000 shares $3.12 million +0.4%N/A1.4 $3.42 10/29/2021908,600 shares $3.38 million -11.8%4.0%1.4 $3.72 10/15/20211,030,000 shares $4.08 million -12.0%4.6%1.6 $3.96 9/30/20211,170,000 shares $4.70 million +60.5%5.2%1.7 $4.02 9/15/2021728,900 shares $3.24 million +8.6%3.2%1.1 $4.45 8/31/2021671,100 shares $3.36 million -10.3%3.0%1.9 $5.01 8/13/2021748,100 shares $3.02 million -30.7%3.3%2.2 $4.04 7/30/20211,080,000 shares $4.72 million -49.8%4.8%3 $4.37 7/15/20212,150,000 shares $9.31 million -4.9%9.6%3.9 $4.33 6/30/20212,260,000 shares $11.59 million +17.7%10.1%4.1 $5.13 6/15/20211,920,000 shares $8.70 million +10.3%8.6%3.6 $4.53 5/28/20211,740,000 shares $6.59 million -0.6%7.8%4.1 $3.79 5/14/20211,750,000 shares $5.53 million +53.5%N/A3.7 $3.16 4/30/20211,140,000 shares $5.18 million +30.7%N/A2.1 $4.54 4/15/2021872,200 shares $3.55 million -7.2%N/A1.4 $4.07 3/31/2021939,500 shares $4.34 million +116.8%N/A1 $4.62 3/15/2021433,400 shares $2.25 million +25.6%N/A0.4 $5.18 2/26/2021345,200 shares $2.12 million -29.4%N/A0.4 $6.14 2/12/2021489,100 shares $3.81 million -29.3%N/A0.5 $7.80 1/29/2021691,900 shares $4.41 million -9.5%N/A0.7 $6.38Market "Famine" Coming (Ad)Market Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicted the 2020 crash a month before it happened...For a limited time, he's revealing his latest forecast here. 1/15/2021764,800 shares $3.70 million +0.9%N/A0.9 $4.84 12/31/2020758,000 shares $2.80 million -0.9%N/A1.2 $3.70 12/15/2020765,000 shares $3.27 million -29.8%N/A1.6 $4.27 11/30/20201,090,000 shares $4.68 million -12.1%N/A1.5 $4.29 11/15/20201,240,000 shares $5.39 million +4.2%N/A1.4 $4.35 10/30/20201,190,000 shares $4.95 million -9.9%N/A1.2 $4.16 10/15/20201,320,000 shares $6.40 million -8.3%N/A0.6 $4.85 9/30/20201,440,000 shares $7.56 million -1.4%N/A0.5 $5.25 9/15/20201,460,000 shares $6.83 million -24.0%N/A0.5 $4.68 8/31/20201,920,000 shares $11.58 million -6.8%N/A0.7 $6.03 8/14/20202,060,000 shares $12.75 million +73.1%N/A0.8 $6.19 7/31/20201,190,000 shares $9.47 million +166.9%N/A0.4 $7.96 7/15/2020445,900 shares $1.82 million +0.7%N/A0.1 $4.08 6/30/2020442,700 shares $2.09 million +61.5%N/A0.1 $4.73 6/15/2020274,200 shares $1.29 million +136.4%N/A0 $4.70 5/29/2020116,000 shares $538,240.00 -87.1%N/A0 $4.64 5/15/2020897,400 shares $5.38 million +187.7%N/A0.2 $5.99 4/30/2020311,900 shares $2.18 million +322.1%N/A0.1 $7.00 4/15/202073,900 shares $110,850.00 +8.7%N/A0.1 $1.50 3/31/202068,000 shares $169,320.00 +161.5%N/A0.1 $2.49 3/13/202026,000 shares $42,380.00 -10.7%N/A0.1 $1.63 2/28/202029,100 shares $33,756.00 +140.5%N/A0.1 $1.16 2/14/202012,100 shares $11,374.00 +80.6%0.4%0.1 $0.94 1/31/20206,700 shares $8,107.00 -86.1%0.2%0 $1.21 1/15/202048,100 shares $65,416.00 +75.6%1.5%0.3 $1.36 12/31/201927,400 shares $48,498.00 -90.8%0.9%0.2 $1.77 CAPR Short Interest - Frequently Asked Questions What is Capricor Therapeutics' current short interest? Short interest is the volume of Capricor Therapeutics shares that have been sold short but have not yet been closed out or covered. As of October 15th, investors have sold 6,180,000 shares of CAPR short. Learn More on Capricor Therapeutics' current short interest. What is a good short interest ratio for Capricor Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CAPR shares currently have a short interest ratio of 2.0. Learn More on Capricor Therapeutics's short interest ratio. Is Capricor Therapeutics' short interest increasing or decreasing? Capricor Therapeutics saw a increase in short interest in October. As of October 15th, there was short interest totaling 6,180,000 shares, an increase of 17.9% from the previous total of 5,240,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Capricor Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Capricor Therapeutics: Leap Therapeutics, Inc. (2.43%), Clearside Biomedical, Inc. (2.61%), ProPhase Labs, Inc. (1.08%), Eyenovia, Inc. (3.57%), NeuroBo Pharmaceuticals, Inc. (0.81%), Tonix Pharmaceuticals Holding Corp. (3.98%), Galmed Pharmaceuticals Ltd. (1.77%), TG Therapeutics, Inc. (23.54%), Prestige Consumer Healthcare Inc. (4.32%), Perrigo Company plc (4.01%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short Capricor Therapeutics stock? Short selling CAPR is an investing strategy that aims to generate trading profit from Capricor Therapeutics as its price is falling. CAPR shares are trading down $0.86 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Capricor Therapeutics? A short squeeze for Capricor Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CAPR, which in turn drives the price of the stock up even further. How often is Capricor Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CAPR, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies Leap Therapeutics Short Squeeze Clearside Biomedical Short Squeeze ProPhase Labs Short Squeeze Eyenovia Short Squeeze NeuroBo Pharmaceuticals Short Squeeze Tonix Pharmaceuticals Short Squeeze Galmed Pharmaceuticals Short Squeeze TG Therapeutics Short Squeeze Prestige Consumer Healthcare Short Squeeze Perrigo Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CAPR) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Capricor Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Capricor Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
